InsiderTape plots every Form 4 on the price chart and flags cluster buys, CEO conviction, and first buys in years the moment they file. Start a free 7-day trial, cancel anytime.
START FREE TRIAL →Steve Aselage, Director, is a corporate insider tracked by InsiderTape across 3 companies. The public record shows 10 open-market SEC Form 4 transactions: 4 purchases worth $537K and 6 sales worth $2.3M, reported from Oct 7, 21 to May 24, 24. Over this period they have been a mix of buying and selling.
| Date | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| May 24, 24 | BCRXBIOCRYST PHARMACEUTICALS INC | BUY | 2.5K | $6.40 | $16K |
| Nov 29, 22 | ACERAcer Therapeutics Inc. | BUY | 409.8K | $1.22 | $500K |
| May 11, 22 | TVTXTravere Therapeutics, Inc. | SELL | 2.6K | $21.92 | $56K |
| Dec 10, 21 | ACERAcer Therapeutics Inc. | BUY | 8.0K | $2.04 | $16K |
| Dec 9, 21 | ACERAcer Therapeutics Inc. | BUY | 2.0K | $2.15 | $4K |
| Nov 16, 21 | TVTXTravere Therapeutics, Inc. | SELL | 31.8K | $29.39 | $935K |
| Nov 5, 21 | TVTXTravere Therapeutics, Inc. | SELL | 10.0K | $26.23 | $262K |
| Nov 2, 21 | TVTXTravere Therapeutics, Inc. | SELL | 3.5K | $30.00 | $105K |
| Nov 1, 21 | TVTXTravere Therapeutics, Inc. | SELL | 5.0K | $29.48 | $147K |
| Oct 7, 21 | TVTXTravere Therapeutics, Inc. | SELL | 32.0K | $26.26 | $840K |